Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

100% cure rate for people with HCV genotype 1 treated with AL-335, odalasvir and simeprevir for 6 or 8 weeks

News
5 October 2016
Hepatitis C treatment

UNITAID and FIND launch initiative to improve diagnostics and treatment for hepatitis C

Editor's pick
UNITAID
4 October 2016
Hepatitis C treatment

Elimination of viral hepatitis by 2030: What's needed and how do we get there?

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
4 October 2016
Hepatitis C treatment

Australia leading world in hepatitis C treatment; but disease more prevalent in Aboriginal people

Editor's pick
ABC Online
29 September 2016
Hepatitis C transmission & prevention

Risk of reinfection is a concern after successful hepatitis C treatment

News
28 September 2016
Hepatitis C treatment

EASL issues new hepatitis C treatment recommendations for all genotypes

News
26 September 2016
Hepatitis C treatment

NICE says yes to another hepatitis C drug

Editor's pick
NICE
26 September 2016
Hepatitis C treatment

Exviera, Viekirax regimen shows high SVR in HCV genotype 1b after 8 weeks

Editor's pick
Healio
26 September 2016
Hepatitis C treatment

New Study: Negotiated Hepatitis C Prescription Drug Costs in United States Often Lower than in Price-Controlled European Countries and Japan

Editor's pick
Yahoo News
20 September 2016
Hepatitis C treatment

HCV treatment is effective and may work as prevention for people who inject drugs

News
20 September 2016
Hepatitis C treatment

Behind Battle Over Drug Prices, Quiet Money From Big Pharma

Editor's pick
Bloomberg
19 September 2016
Access to healthcare

NHS funding cuts ‘forcing people to buy medicine through Facebook’

Editor's pick
The Independent
16 September 2016
Hepatitis C treatment

Inventor of Hepatitis C Cure Wins a Major Prize—and Turns to the Next Battle

Editor's pick
Scientific American
13 September 2016
Hepatitis C treatment

Ethiopia unable to provide effective national response to viral hepatitis

Editor's pick
Healio
12 September 2016
Hepatitis C treatment

UK: More options to be made available to treat hepatitis C

Editor's pick
NICE press release
12 September 2016
Hepatitis C symptoms & diagnosis

Effective antiviral treatment reduces fatigue in people with chronic hepatitis C

News
12 September 2016
People who inject drugs

INHSU 2016 opens with focus on hepatitis C prevention and treatment for people who inject drugs

News
9 September 2016
Access to healthcare

Letter to Gilead Sciences on attempts to remove generic sofosbuvir from Ukraine

Editor's pick
MSF
7 September 2016
Access to healthcare

Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

Editor's pick
STAT
7 September 2016
Hepatitis C treatment

VA estimates 107000 vets have undiagnosed or untreated hepatitis C

Editor's pick
Stars and Stripes
7 September 2016
People who inject drugs

New research supports hep C treatment for people who use drugs

Editor's pick
Eurekalert Medicine & Health
7 September 2016
Access to healthcare

High cost hampers treatment of hepatitis B, C in Vietnam: experts

Editor's pick
Thanh Nien Daily
31 August 2016
Pharmaceutical industry

University of Minnesota sues Gilead Sciences over hepatitis drugs

Editor's pick
Minneapolis Star Tribune
31 August 2016
Pharmaceutical industry

Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

Editor's pick
UPI.com
19 August 2016